GenBioPro
Jump to navigation
Jump to search
| Industry | Pharmaceutical |
|---|---|
| Headquarters | United States |
Area served | United States |
| Products | mifepristone |
| Website | https://genbiopro.com/ |
GenBioPro is a United States pharmaceutical company which makes and distributes a generic version of the medication abortion drug mifepristone.
History
[edit | edit source]In 2019 GenBioPro obtained Food and Drug Administration (FDA) authorization to sell a generic version of mifepristone (before that, Danco Laboratories was the only company that distributed it in the United States).[1][2] Despite the FDA saying that it tries to approve generic drug applications in 10 months, this application was approved after 10 years (the company applied in 2009).[3]
In 2023, GenBioPro sued the FDA to obtain a legal judgement confirming that mifepristone could continue to be sold, in spite of anti-abortion laws passed in some states.[4][5]
See also
[edit | edit source]References
[edit | edit source]- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
- ^ "Generic abortion pill manufacturer sues FDA in effort to preserve access" Sarah McCammon April 19, 2023 NPR https://www.npr.org/2023/04/19/1170806176/abortion-pill-mifepristone-supreme-court-fda-generic-genbiopro
- ^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).